Retatrutide Shows 28% Weight Loss in Phase 3 Trial - Top_Thought_Leaders - MDSpire

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

  • By

  • Kathryn Wighton

  • May 21, 2026

Share

Top Thought Leaders in Internal Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

Related Content